Physician profile
Anantha N Kamath
NPI 1528055027
$6,805.18
in general payments reported to CMS, 2019-2025
38 companies · $1,337 in 2025
The $1,337 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,438 · 2020: $549 · 2021: $297 · 2022: $750 · 2023: $1,932 · 2024: $502 · 2025: $1,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,563 · Travel and Lodging: $993 · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,562.59 |
| Travel and Lodging | $992.55 |
| Education | $216.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,354.91 | 2023 | Intracept |
| Abbott Laboratories | $940.87 | 2021-2025 | Proclaim, Octrode, Eterna |
| Boston Scientific Corporation | $935.09 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $414.84 | 2019-2024 | Senza |
| Scilex Pharmaceuticals INC. | $305.55 | 2019-2024 | Ztlido |
| Vertiflex, INC. | $284.01 | 2019 | |
| Medtronic USA, INC. | $258.48 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $231.22 | 2019-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $230.21 | 2019-2025 | Relistor |
| Medtronic, INC. | $221.76 | 2022-2023 | Kyphon Express II Kyphopak Tray |
| Biodelivery Sciences International, INC. | $191.52 | 2019-2020 | |
| Painteq LLC | $132.86 | 2022-2024 | Painteq |
| Stimwave Technologies Incorporated | $128.83 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $110.02 | 2019-2024 | Euflexxa |
| Virtus Pharmaceuticals LLC | $107.82 | 2025 | Levorphanol Tartrate |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $96.56 | 2023-2025 | Horizant, Horizant |
| Horizon Therapeutics Plc | $88.05 | 2019-2021 | |
| Assertio Therapeutics, INC. | $78.59 | 2019 | |
| Biotronik Nro, INC. | $78.12 | 2025 | Prospera |
| Globus Medical, INC. | $69.68 | 2025 | Senza |
| Kaleo, INC. | $60.56 | 2019 | |
| Vertical Pharmaceuticals, LLC | $55.95 | 2019 | |
| Arbor Pharmaceuticals, INC. | $54.43 | 2019-2022 | |
| Vertos Medical, INC. | $52.58 | 2024 | Mild Device Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $46.62 | 2019 | |
| Sentynl Therapeutics, INC. | $43.95 | 2019 | |
| Pfizer INC. | $42.96 | 2019-2020 | |
| Nalu Medical, INC. | $32.21 | 2024 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $26.19 | 2024 | Evoke |
| Protega Pharmaceutials INC | $25.90 | 2023 | Roxybond |
| Tonix Medicines, INC. | $16.69 | 2025 | Tonmya |
| Shionogi INC | $15.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.10 | 2020 | |
| Merit Medical Systems INC | $13.98 | 2020 | |
| Almatica Pharma LLC | $13.40 | 2021 | |
| Redhill Biopharma INC. | $11.69 | 2021 | |
| Lilly USA, LLC | $11.50 | 2021 | |
| Galt Pharmaceuticals, LLC | $8.20 | 2023 | Orphengesic Forte |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anantha Kamath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.